Related references
Note: Only part of the references are listed.Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance
Eliana M. C. Tacconi et al.
EMBO MOLECULAR MEDICINE (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer
Ken-ichi Takayama et al.
ENDOCRINOLOGY (2019)
Runx2, an inducer of osteoblast and chondrocyte differentiation
Toshihisa Komori
HISTOCHEMISTRY AND CELL BIOLOGY (2018)
Genetic regulation of the RUNX transcription factor family has antitumor effects
Ken Morita et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
Daisuke Obinata et al.
CANCERS (2017)
ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells
Toshiro Migita et al.
CANCER SCIENCE (2017)
Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth
D. Obinata et al.
ONCOGENE (2016)
MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5′ end resection
Vera Boersma et al.
NATURE (2015)
RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer
Ken-ichi Takayama et al.
ONCOTARGET (2015)
Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth
Daisuke Obinata et al.
CANCER SCIENCE (2014)
Androgen receptor antagonists for prostate cancer therapy
Christine Helsen et al.
ENDOCRINE-RELATED CANCER (2014)
Human single-stranded DNA binding protein 1 (hSSB1/NABP2) is required for the stability and repair of stalled replication forks
Emma Bolderson et al.
NUCLEIC ACIDS RESEARCH (2014)
Synthesis and preliminary in vitro biological evaluation of 7α-testosterone-chlorambucil hybrid designed for the treatment of prostate cancer
Dominic Bastien et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer
Daisuke Obinata et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide
Jevgenij A. Raskatov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
Jennifer A. Locke et al.
CANCER RESEARCH (2008)
Single-stranded DNA-binding protein hSSB1 is critical for genomic stability
Derek J. Richard et al.
NATURE (2008)
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth
Qianben Wang et al.
MOLECULAR CELL (2007)
Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide
Nicholas G. Nickols et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
DNA-PK phosphorylation sites on Oct-1 promote cell survival following DNA damage
C. Schild-Poulter et al.
ONCOGENE (2007)
Synthesis and biological properties of sequence-specific DNA-alkylating pyrrole-imidazole polyamides
Toshikazu Bando et al.
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding
J Shamash et al.
BRITISH JOURNAL OF CANCER (2005)
Recognition of the DNA minor groove by pyrrole-imidazole polyamides
PB Dervan et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2003)
Molecular recognition of DNA by small molecules
PB Dervan
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Share Paper
